Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mutagenesis and free energy calculations to optimize the ProRgpB inhibitor loop and identify variants with higher affinity for <i>Porphyromonas gingivalis</i> RgpB.

RSC advances·2026
Same author

Nature Counts to Three: Universal Mg-Pinch Motif Polarizes the Cleaved Bond in NTP-Processing Enzymes.

Journal of the American Chemical Society·2026
Same author

20 Years of the ISCB Student Council Symposium: shaping computational biology and future leaders.

Bioinformatics advances·2026
Same author

Drug Repurposing Uncovers New Chemical Scaffolds as Potent Urease Inhibitors: A Comprehensive Computational Study.

International journal of molecular sciences·2026
Same author

Antimicrobial Activity of LysX and LysP Endolysins Against <i>Pseudomonas syringae</i> pv. <i>syringae</i> and <i>Xanthomonas arboricola</i> pv. <i>juglandis</i>.

Plants (Basel, Switzerland)·2026
Same author

Reply.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2025

相关实验视频

Updated: Jun 9, 2026

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

10.5K

虚拟查方法的比较数据分析,用于预测尿素抑制活性.

Elizabeth Valdés-Muñoz1,2, Gabriel J Olguín-Orellana3, Sofía E Ríos-Rozas2

  • 1Doctorate in Translational Biotechnology, Center for Biotechnology of Natural Resources, Universidad Catolica del Maule, Talca 3480094, Chile.

ACS omega
|November 3, 2025
PubMed
概括

这项研究通过比较对接和数据融合方法来优化基于结构的虚拟选 (SBVS) 药物发现. 合并对接 (ED) 和分子力学/通用化天生的表面积 (MM-GBSA) 显示出最佳的化合物排名,最小的数据融合证明是最强大的.

更多相关视频

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

617
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

相关实验视频

Last Updated: Jun 9, 2026

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

10.5K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

617
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

科学领域:

  • 计算化学和化学信息学
  • 药物的发现和开发.
  • 分子建模和模拟分子模型

背景情况:

  • 基于结构的虚拟查 (SBVS) 对于识别候选药物至关重要.
  • SBVS的准确性在很大程度上取决于所选择的方法,评分功能和数据处理.
  • 优化SBVS协议对于高效的药物发现管道至关重要.

研究的目的:

  • 系统地评估和比较不同的SBVS协议变体用于药物发现.
  • 评估数据融合技术的影响,以及对联体排序精度的定位数.
  • 改进SBVS工作流程,以提高对治疗标的联体优先级.

主要方法:

  • 采用了五种SBVS变体:分子对接,诱导适合对接 (IFD),量子极化连接体对接 (QPLD),组合对接 (ED) 和MM-GBSA.
  • 利用了PDB中的*Helicobacter pylori*尿酶的四个晶体结构.
  • 使用相关性指标 (斯皮尔曼,皮尔森) 和错误指标 (MAE,RMSE,IRM) 以及六种数据融合技术来评估性能.

主要成果:

  • 合并对接 (ED) 和MM-GBSA在复合排名中表现出卓越的表现.
  • 与ED相比,MM-GBSA在绝对有约束力的能量预测中显示出更高的错误.
  • 最小数据融合方法在不同数量的对接姿势中被证明是稳健的.
  • pIC50值为亲和力预测产生了比IC50值更高的皮尔森相关性.

结论:

  • MM-GBSA和ED是SBVS中复合排名的有效方法.
  • 最小数据融合是聚合对接结果的可靠策略.
  • 在相关性分析中,pIC50是更适合用于亲和力预测的指标.
  • 优化的SBVS工作流可以提高药物发现活动的联体优先级.